ATE141335T1 - Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin - Google Patents

Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin

Info

Publication number
ATE141335T1
ATE141335T1 AT90300287T AT90300287T ATE141335T1 AT E141335 T1 ATE141335 T1 AT E141335T1 AT 90300287 T AT90300287 T AT 90300287T AT 90300287 T AT90300287 T AT 90300287T AT E141335 T1 ATE141335 T1 AT E141335T1
Authority
AT
Austria
Prior art keywords
cholesterol
hdl
proportion
increasing
vascular diseases
Prior art date
Application number
AT90300287T
Other languages
English (en)
Inventor
Robert Q Maines
Original Assignee
Robert Q Maines
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Q Maines filed Critical Robert Q Maines
Application granted granted Critical
Publication of ATE141335T1 publication Critical patent/ATE141335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT90300287T 1989-01-13 1990-01-10 Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin ATE141335T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29708089A 1989-01-13 1989-01-13

Publications (1)

Publication Number Publication Date
ATE141335T1 true ATE141335T1 (de) 1996-08-15

Family

ID=23144775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90300287T ATE141335T1 (de) 1989-01-13 1990-01-10 Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin

Country Status (5)

Country Link
US (1) US5453358A (de)
EP (1) EP0378395B1 (de)
AT (1) ATE141335T1 (de)
CA (1) CA2007645A1 (de)
DE (1) DE69028023T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375894C (en) 1999-06-21 2012-05-22 Daiichi Pure Chemicals Co., Ltd. Reaction accelerator-enchanced activity of cholesterol metabolizing enzymes in methods of quantifying cholesterol
US20050074828A1 (en) * 2003-07-16 2005-04-07 Dimagno Theodore John Uae of lipase for high-density lipoprotein cholesterol detection
WO2014145678A2 (en) * 2013-03-15 2014-09-18 Health Diagnostic Laboratory, Inc. System and method for assessing quantities or sizes of lipoprotein particles from lipoprotein particle compositions
US20150260631A1 (en) * 2014-03-17 2015-09-17 Health Diagnostic Laboratory, Inc. System and method for assessing quanitites or sizes of lipoprotein particles from lipoprotein particle compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186251A (en) * 1973-03-01 1980-01-29 Miles Laboratories, Inc. Composition and method for determination of cholesterol
US3884764A (en) * 1974-03-25 1975-05-20 Eastman Kodak Co Method and composition for blood serum cholesterol analysis
JPS51139634A (en) * 1975-05-23 1976-12-02 Kazuhiko Takamiya A composition for blood pressure regulation
US4184921A (en) * 1976-03-25 1980-01-22 Boehringer Mannheim Gmbh Process and reagent for determining cholesterol
US4414326A (en) * 1978-04-24 1983-11-08 Goldberg Jack M Diagnostic agents
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
US4466958A (en) * 1981-03-18 1984-08-21 Morrison L M Food supplement
JPS61118323A (ja) * 1984-11-12 1986-06-05 Pola Chem Ind Inc 血清脂質改善作用を有する組成物
DE3533288A1 (de) * 1985-09-18 1987-03-26 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von hdl-cholesterin im serum
JPS62263119A (ja) * 1986-05-08 1987-11-16 Nippon Oil & Fats Co Ltd リン脂質製剤透明カプセルの製造法
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
DE3786650T2 (de) * 1986-12-19 1993-12-23 Procter & Gamble Nährzusammenstellung mit höherem Blutcholesterol herabsetzenden Eigenschaften.
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
FR2624014B1 (fr) * 1987-12-02 1991-07-12 Adera Manche Nouveaux complexes macromoleculaires d'origine vegetale, leur procede de preparation et leur utilisation a titre d'agent hypocholesterolemiant

Also Published As

Publication number Publication date
EP0378395A2 (de) 1990-07-18
EP0378395A3 (de) 1992-07-01
EP0378395B1 (de) 1996-08-14
DE69028023D1 (de) 1996-09-19
US5453358A (en) 1995-09-26
DE69028023T2 (de) 1997-03-06
CA2007645A1 (en) 1990-07-13

Similar Documents

Publication Publication Date Title
DE69729654D1 (de) Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit
ES2150936T3 (es) Deteccion inmunoquimica de productos finales de glucosilacion avanzada in vivo.
IL149171A0 (en) Elisa for vegf
ATA194989A (de) Verfahren zum nachweis und zur bestimmung von humanserumalbumin in biologischen fluessigkeiten mit hilfe fluorogener cyanin-farbstoffe
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
ATE181599T1 (de) Methode zur bestimmung von hämoglobinaddukten
ATE191976T1 (de) Verfahren zum nachweis von knochen- und anderen bindegewebeerkrankungen in menschen und tieren
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
ATE141335T1 (de) Verfahren zur bestimmung des cholesterins, zum nachweis von gefässkrankheiten und zur anhebung des anteils an hdl-cholesterin
ATE38521T1 (de) Neues protein (pp13), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung.
HEIKURA et al. Cholic acid and chenodeoxycholic acid concentrations in serum during infancy and childhood
Sweeney Alterations in tissue and serum ceruloplasmin concentration associated with inflammation
FI882122A0 (fi) In vitro -diagnostinen menetelmä periodontaalisten sairauksien toteamiseksi
AU681374B2 (en) Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood
AU681624B2 (en) Diagnosis and monitoring of colon cancer patients by measurement of NCA 50/90 in blood
DE69221104D1 (de) Immunoassay für NCA-BT in Blutproben von Brustkrebspatientinnen
ATE209359T1 (de) Bestimmung von freiem und komplexiertem trypsinogen-2
IL85897A0 (en) Method of diagnosing obesity caused by a genetic abnormality
DD252443B3 (de) Verfahren und messanordnung zur bestimmung von veraenderungen biologischer gewebe
EP0155676A3 (de) Verfahren zur Gewinnung der globulären Domäne von Basalmembrankollagen und immunologische Bestimmung von Basalmembranmaterial und Autoantikörpern
FI903637A7 (fi) Diagnostisia analyysimenetelmiä ja niiden käyttö kliinisten tilojen määrittämiseen
Scharrel et al. Electrophoretic Studies on Proteinuria on Calcium Oxalate Stone Patients
DE3887314D1 (de) Methode zum nachweis basischer fötaler proteine im urin und dafür geeigneter analysesatz.
ATE45224T1 (de) Verfahren zur diagnose von a.i.d.s.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties